Ken Griffin Neuro Sense Therapeutics Ltd. Call Options Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
16Shares Held
443KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY79.9KShares$97,4780.0% of portfolio
-
Squarepoint Ops LLC New York, NY49.9KShares$60,9080.0% of portfolio
-
Meitav Dash Investments LTD40KShares$48,8000.0% of portfolio
-
Jane Street Group, LLC New York, NY28.7KShares$35,0000.0% of portfolio
-
Hrt Financial LP New York, NY21.7KShares$26,4660.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14.2M